Bioactive Peptide Therapy for Dental Pulp Regeneration: A Comprehensive Review

Abstract

Bioactive peptide therapy has emerged as a promising frontier in dental pulp regeneration, aiming to address the limitations of traditional endodontic treatments. This review synthesizes current scientific evidence on the clinical application, mechanisms, and outcomes of bioactive peptides in dental pulp healing. The discussion encompasses epidemiological context, pathophysiology, risk factors, diagnostic criteria, and the latest advances in regenerative endodontics. Special emphasis is placed on the molecular basis and practical implications for clinicians, underpinned by guideline-based recommendations and expert consensus.

Introduction

Regeneration of dental pulp tissue represents a paradigm shift in endodontic therapy, moving from conventional obturation to biologically based strategies aimed at restoring tissue vitality. Bioactive peptides short amino acid chains with specific biological functions have garnered substantial interest for their capacity to modulate cellular behavior, promote angiogenesis, and orchestrate tissue repair. This review provides an in-depth analysis of bioactive peptide therapy in dental pulp regeneration, integrating mechanistic insights, clinical outcomes, and future perspectives relevant to healthcare professionals in dentistry and oral medicine.

Epidemiology / Disease Burden

Dental caries and traumatic injuries are leading causes of pulp tissue damage and necrosis, with a global prevalence affecting billions. According to the Global Burden of Disease Study, untreated dental caries in permanent teeth is among the most common health conditions worldwide. Irreversible pulpitis and pulp necrosis frequently necessitate root canal therapy (RCT), which, while effective in infection control, fails to restore the biological function of the pulp-dentin complex. The limitations of conventional treatments underscore the need for regenerative approaches that can re-establish pulp vitality and function.

Pathophysiology

The dental pulp is a specialized connective tissue, richly vascularized and innervated, playing a critical role in tooth development, nutrition, and defense. Pathological insults such as caries or trauma trigger a cascade of inflammatory responses leading to cellular apoptosis, necrosis, and loss of pulp vitality. The inability of the adult dental pulp to fully regenerate after severe injury is attributed to limited cell recruitment, inadequate vascular supply, and an inhibitory microenvironment. Bioactive peptides intervene at multiple points in this cascade, modulating cellular signaling pathways involved in proliferation, migration, differentiation, and angiogenesis.

Risk Factors

Key risk factors for pulp pathosis include deep carious lesions, extensive restorative procedures, dental trauma, and systemic conditions affecting immune response or vascularity. Patient-specific factors such as age, comorbidities (e.g., diabetes), and genetic predispositions may further impair regenerative capacity. Iatrogenic factors, including over-instrumentation and chemical irritation during endodontic procedures, also contribute to pulp damage and may influence the success of regenerative therapies.

Clinical Features

Clinically, pulp pathology manifests along a spectrum from reversible pulpitis, characterized by transient pain and sensitivity, to irreversible pulpitis and pulp necrosis, presenting with persistent pain, spontaneous symptoms, and periapical pathology. Pulpal inflammation may be asymptomatic in chronic cases, detected only via radiographic changes or sensitivity testing. The clinical objective of regenerative endodontics is to restore vitality in teeth with compromised pulps, ideally resulting in continued root development (in immature teeth), resolution of symptoms, and preservation of tooth structure.

Diagnosis

Diagnosis of pulp status relies on a combination of clinical examination, pulp vitality testing (thermal, electric), and radiographic assessment. Recent advances in molecular diagnostics, including biomarkers of inflammation and tissue injury, offer potential for more precise assessment of pulp viability. Accurate diagnosis is paramount for selecting candidates for regenerative procedures and monitoring therapeutic outcomes.

Treatment & Management

Traditional management of pulp necrosis involves non-vital therapy (RCT), which eliminates infection but does not restore biologic function. Regenerative endodontic procedures (REPs) aim to reconstitute pulp-like tissue using scaffolds, signaling molecules, and stem/progenitor cells. Bioactive peptides have emerged as a key component of these strategies due to their ability to modulate cellular microenvironments, recruit endogenous stem cells, and direct tissue-specific differentiation. Clinical protocols typically involve disinfection of the root canal system, placement of a peptide-laden scaffold, and sealing with a biocompatible restorative material. The selection and delivery of bioactive peptides are critical variables influencing regenerative outcomes.

Recent Advances / Emerging Therapies

Recent research has identified several classes of bioactive peptides with potential in dental pulp regeneration, including self-assembling peptides, dentin matrix protein-derived peptides (e.g., DMP1, DSPP), and synthetic peptides mimicking growth factor activity. Studies demonstrate that these peptides promote odontoblastic differentiation, enhance angiogenesis, and stimulate mineralized tissue formation in vitro and in vivo. Notably, self-assembling peptide hydrogels provide a supportive matrix facilitating cell migration and tissue integration, while growth factor-mimetic peptides offer targeted activation of regenerative pathways without the risks associated with recombinant proteins. Ongoing clinical trials are evaluating the safety and efficacy of these approaches, with preliminary results indicating favorable outcomes in terms of radiographic healing, root maturation, and pulp vitality.

Guideline Recommendations

Current guidelines from endodontic societies and consensus panels endorse regenerative endodontic procedures as a treatment option for immature teeth with necrotic pulps, with expanding indications as evidence accumulates. The American Association of Endodontists (AAE) supports the use of biologically based therapies, including bioactive peptides, within well-defined protocols emphasizing case selection, infection control, and meticulous follow-up. Clinicians are advised to remain updated on emerging evidence, exercise clinical judgment in the selection of regenerative agents, and participate in outcome registries to advance the field.

Conclusion

Bioactive peptide therapy represents a transformative advance in dental pulp regeneration, offering the potential to restore natural tissue architecture and function beyond the capabilities of traditional endodontics. While significant progress has been made in elucidating the mechanisms and optimizing clinical protocols, further research is needed to refine peptide formulations, delivery systems, and patient selection criteria. The integration of bioactive peptides into regenerative endodontic practice holds promise for improving patient outcomes and redefining the future of vital pulp therapy in dentistry.